Skip to Main Content

Paper Details

Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.
Cancer Discov
1
2024
CTLA4, HGG, Lynch syndrome, MAPK, RAS, RRD, RRD-, anti-PD1, biallelic mismatch-repair deficiency, high-grade glioma, high-grade gliomas, patient, patients, replication, replication repair deficient, tumor
Author NameAffiliation
David S ZieglerSydney Children's Hospital
Stefan S BielackKlinikum Stuttgart Olgahospital
Kim E NicholsSt. Jude Children's Research Hospital
Vijay RamaswamyHospital for Sick Children
David MalkinHospital for Sick Children
David MalkinHospital for Sick Children
Gad GetzBroad Institute of the Massachusetts Institute of Technology and Harvard
Gad GetzBroad Institute of the Massachusetts Institute of Technology and Harvard
Cynthia HawkinsHospital for Sick Children
Cynthia HawkinsHospital for Sick Children
Eric BouffetThe Hospital for Sick Children, University of Toronto
Uri TaboriHospital for Sick Children
  • 1 - 12

Datasets

Release 1.2